Pharmacological Advances in Managing Obesity-Induced Diabetes: Beyond Metformin and Insulin
2026 | Research Output Journal of Public Health and Medicine | Pp. 30-35
Type 2 diabetes (T2D) in the context of obesity reflects impaired metabolic flexibility across adipose tissue, liver, muscle, and islets. While metformin and insulin remain foundational, the modern pharmacologic toolkit now targets weight, immunometabolism, o...